Mirna Bulatović

952 total citations
18 papers, 526 citations indexed

About

Mirna Bulatović is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mirna Bulatović has authored 18 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Mirna Bulatović's work include Metal complexes synthesis and properties (9 papers), Ferrocene Chemistry and Applications (4 papers) and Organometallic Compounds Synthesis and Characterization (4 papers). Mirna Bulatović is often cited by papers focused on Metal complexes synthesis and properties (9 papers), Ferrocene Chemistry and Applications (4 papers) and Organometallic Compounds Synthesis and Characterization (4 papers). Mirna Bulatović collaborates with scholars based in Serbia, Germany and Spain. Mirna Bulatović's co-authors include Sanja Mijatović, Danijela Maksimović‐Ivanić, Marija Mojić, Goran N. Kaluđerović, Eun Sun Kim, Lixin Zhang, Andrea Gambotto, Yusi Fang, Robert P. Edwards and Anda Vlad and has published in prestigious journals such as Angewandte Chemie International Edition, Oncogene and European Journal of Pharmacology.

In The Last Decade

Mirna Bulatović

18 papers receiving 520 citations

Peers

Mirna Bulatović
Lili Chu China
Mirna Bulatović
Citations per year, relative to Mirna Bulatović Mirna Bulatović (= 1×) peers Lili Chu

Countries citing papers authored by Mirna Bulatović

Since Specialization
Citations

This map shows the geographic impact of Mirna Bulatović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirna Bulatović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirna Bulatović more than expected).

Fields of papers citing papers by Mirna Bulatović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirna Bulatović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirna Bulatović. The network helps show where Mirna Bulatović may publish in the future.

Co-authorship network of co-authors of Mirna Bulatović

This figure shows the co-authorship network connecting the top 25 collaborators of Mirna Bulatović. A scholar is included among the top collaborators of Mirna Bulatović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirna Bulatović. Mirna Bulatović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mojić, Marija, Mirna Bulatović, Damián Pérez‐Quintanilla, et al.. (2022). Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph3Sn(CH2)8OH. Biomaterials Advances. 140. 213054–213054. 4 indexed citations
2.
Maksimović‐Ivanić, Danijela, Mirna Bulatović, Igor Golić, et al.. (2019). The interaction between SBA-15 derivative loaded with Ph3Sn(CH2)6OH and human melanoma A375 cell line: uptake and stem phenotype loss. JBIC Journal of Biological Inorganic Chemistry. 24(2). 223–234. 23 indexed citations
3.
Grabosch, Shannon, Mirna Bulatović, Tianzhou Ma, et al.. (2018). Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles. Oncogene. 38(13). 2380–2393. 214 indexed citations
5.
Ljujić, Mila, Sanja Mijatović, Mirna Bulatović, et al.. (2016). α1-антитрипсин влияет на индуцируемую U0126 цитотоксичность в линии клеток рака толстой кишки НСТ116. Молекулярная биология. 50(1). 174–178. 3 indexed citations
6.
Ljujić, Mila, Sanja Mijatović, Mirna Bulatović, et al.. (2016). Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines. Pathology & Oncology Research. 23(2). 335–343. 4 indexed citations
7.
Ljujić, Mila, Sanja Mijatović, Mirna Bulatović, et al.. (2016). ALPHA-1 antitrypsin affects U0126-induced cytotoxicity in colon cancer cell line (HCT116). Molecular Biology. 50(1). 153–156. 3 indexed citations
8.
Maksimović‐Ivanić, Danijela, Marija Mojić, Mirna Bulatović, et al.. (2015). The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K. Leukemia Research. 39(10). 1088–1095. 25 indexed citations
9.
Bulatović, Mirna, Marija Mojić, Evamarie Hey‐Hawkins, et al.. (2015). Improved in vitro antitumor potential of (O,O′-Diisobutyl-ethylenediamine-N,N′-di-3-propionate)tetrachloridoplatinum(IV) complex under normoxic and hypoxic conditions. European Journal of Pharmacology. 760. 136–144. 9 indexed citations
10.
Ranđelović, Ivan, Danijela Maksimović‐Ivanić, Sanja Mijatović, et al.. (2014). Anticancer Potential of (Pentamethylcyclopentadienyl)chloridoiridium(III) Complexes Bearing κP and κPS‐Coordinated Ph2PCH2CH2CH2S(O)xPh (x=0–2) Ligands. ChemMedChem. 9(7). 1586–1593. 14 indexed citations
11.
Bulatović, Mirna, Danijela Maksimović‐Ivanić, Santiago Gómez‐Ruiz, et al.. (2014). Organotin(IV)‐Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment. Angewandte Chemie International Edition. 53(23). 5982–5987. 89 indexed citations
12.
Bulatović, Mirna, Danijela Maksimović‐Ivanić, Santiago Gómez‐Ruiz, et al.. (2014). Organozinn(IV)‐beladenes mesoporöses SiO2 als biokompatible Strategie bei der Krebstherapie. Angewandte Chemie. 126(23). 6092–6097. 1 indexed citations
13.
Mijatović, Sanja, Ivan Ranđelović, Mirna Bulatović, et al.. (2013). Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x = 0–2) ligands. European Journal of Medicinal Chemistry. 69. 216–222. 28 indexed citations
14.
Mojić, Marija, Vladimir B. Arion, Mirna Bulatović, et al.. (2013). Synthesis, X-ray structure and strong in vitro cytotoxicity of novel organoruthenium complexes. Journal of Organometallic Chemistry. 749. 142–149. 9 indexed citations
15.
Ajdžanović, Vladimir, Marija Mojić, Danijela Maksimović‐Ivanić, et al.. (2013). Membrane Fluidity, Invasiveness and Dynamic Phenotype of Metastatic Prostate Cancer Cells after Treatment with Soy Isoflavones. The Journal of Membrane Biology. 246(4). 307–314. 24 indexed citations
16.
Mijatović, Sanja, Mirna Bulatović, Marija Mojić, et al.. (2013). Study of the anticancer properties of methyl- and phenyl-substituted carbon- and silicon-bridged ansa-titanocene complexes. Journal of Organometallic Chemistry. 751. 361–367. 8 indexed citations
17.
Kaluđerović, Goran N., Sanja Mijatović, Mirna Bulatović, et al.. (2012). Platinum(ii/iv) complexes containing ethylenediamine-N,N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells. Metallomics. 4(9). 979–979. 38 indexed citations
18.
Vučković, Ivan, Marija Mojić, Mirna Bulatović, et al.. (2012). Novel methylene modified cyclohexyl ethylenediamine-N,N′-diacetate ligands and their platinum(IV) complexes. Influence on biological activity. Journal of Inorganic Biochemistry. 109. 40–48. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026